Nephrology & Kidney Research
Advancing Kidney Impairment Clinical Research
Kidney impairment affects millions of individuals worldwide and can significantly impact overall health and quality of life. CenExel partners with sponsors to advance innovative therapies for chronic kidney disease (CKD), renal impairment, and related metabolic conditions through specialized clinical research and experienced patient care.
Leading Kidney Impairment Clinical Research
CenExel delivers specialized kidney impairment clinical trials through experienced nephrology investigators, advanced research capabilities, and diverse patient populations. Our sites support sponsors with efficient enrollment, precise protocol execution, and high-quality data collection from early-phase through late-phase renal studies.
Improve Patient Outcomes
Accelerate Clinical Development
Kidney Conditions We Research
Our nephrology research sites support a broad range of kidney impairment and renal-related conditions across adult and senior populations.
- Chronic Kidney Disease (CKD)
- Acute Kidney Injury (AKI)
- Diabetic Nephropathy
- End-Stage Renal Disease (ESRD)
- Polycystic Kidney Disease
- Hypertension-Related Kidney Disease
- Glomerulonephritis
- Lupus Nephritis
Why Sponsors Choose CenExel for Kidney Research
CenExel provides scientific expertise, operational excellence, and access to diverse patient populations for kidney impairment clinical trials.
01
Expert Nephrology Teams
Our experienced investigators and site staff support efficient renal study execution and patient monitoring.
02
Biomarker & Lab Expertise
Advanced renal biomarker testing and laboratory coordination improve study accuracy and efficiency.
03
Diverse Patient Access
Access to broad patient populations across multiple U.S. research locations enhances recruitment success.
04
High-Quality Trial Execution
Our proven enrollment strategies help accelerate kidney impairment clinical trial timelines.
Supported Kidney Research Trial Phases
CenExel supports early and late-phase nephrology research studies from proof-of-concept through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatry research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.






